Skip to main content
Premium Trial:

Request an Annual Quote

Roche: Christoph Franz, Severin Schwan, Thomas Schinecker

Roche announced that Christoph Franz, the company's current chairman of the board of directors, will not seek re-election in 2023. As a result, the firm's current CEO Severin Schwan will be proposed for the chairman position, while Roche Diagnostics CEO Thomas Schinecker will take over as the company's CEO, effective March 15.

Franz has served as chairman since 2014 and has been on the board since 2011. Schwan, meantime, has been a member of the corporate executive committee since 2006 and has served as CEO since 2008. He became a member of the board in 2013.

Schinecker has been CEO of Roche Diagnostics and a member of the corporate executive committee since 2019 and previously served in a variety of leadership positions at the company. 

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.